Drug Profile
Chondroitin sulfate/xanthan gum - Laboratorios Sophia
Alternative Names: CS/XG; PRO 148Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Laboratorios Sophia
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Dry eyes
Most Recent Events
- 09 Sep 2016 Phase-III development is ongoing in Mexico
- 01 Nov 2013 Phase-III clinical trials in Dry eyes in Mexico (Ophthalmic)
- 03 Aug 2012 Laboratorios Sophia plans a phase III trial for Dry eyes in Mexico (NCT01657253)